Tumor suppressor Lats2 is a member of the conserved Dbf2 kinase family. It localizes to the centrosome and has been implicated in regulation of the cell cycle and apoptosis. However, the in vivo function of this kinase remains unclear. Here, we show that complete disruption of the gene encoding Lats2 in mice causes developmental defects in the nervous system and embryonic lethality. Furthermore, mutant cells derived from total LATS2-knockout embryos exhibit mitotic defects including centrosome fragmentaion and cytokinesis defects, followed by nuclear enlargement and multinucleation. We show that Mob1 family, a regulator of mitotic exit, associates with Lats2 to induce its activation. We also show that the complete LATS2-knockout cells exhibit an acceleration of exit from mitosis and marked down-regulation of critical mitotic regulators. These results suggest that Lats2 plays an essential mitotic role in coordinating accurate cytokinesis completion, governing the stabilization of other mitotic regulators.
Tumor suppressor Lats2 is a member of the conserved Dbf2 kinase family. It localizes to the centrosome and has been implicated in regulation of the cell cycle and apoptosis. However, the in vivo function of this kinase remains unclear. Here, we show that complete disruption of the gene encoding Lats2 in mice causes developmental defects in the nervous system and embryonic lethality. Furthermore, mutant cells derived from total LATS2-knockout embryos exhibit mitotic defects including centrosome fragmentaion and cytokinesis defects, followed by nuclear enlargement and multinucleation. We show that Mob1 family, a regulator of mitotic exit, associates with Lats2 to induce its activation. We also show that the complete LATS2-knockout cells exhibit an acceleration of exit from mitosis and marked down-regulation of critical mitotic regulators. These results suggest that Lats2 plays an essential mitotic role in coordinating accurate cytokinesis completion, governing the stabilization of other mitotic regulators.
Many human malignant tumors exhibit mitotic defects such as centrosome aberration, abnormal spindle formation, chromosome missegregation and defective cytokinesis. Chromosome instability phenotypes, or aneuploidies, are the major causative factors of spontaneous abortion, perinatal defects and malignant tumor progression. Therefore, mitosis is stringently controlled by various regulators and the checkpoint machinery (1, 2, 3, 4, 5) . In particular, failure of cytokinesis causes severe cell division defects such as tetraploidy, with nuclear enlargement and multinucleation. In contrast to organisms such as yeasts and nematodes, in mammalian cells the molecular mechanisms underlying exit of mitosis and cytokinesis remains unclear (6, 7, 8, 9) .
Lats (large tumor suppressor)/WARTS (Wts) was originally identified as a serine/threonine kinase tumor suppressor in Drosophila as its inactivation resulted in overproliferation phenotypes and developmental defects in mosaic animals (10, 11) . Drosophila Lats coordinates cell proliferation and cell death with the protein kinase Hippo (Hpo) and the scaffold protein Salvador (Sav) by regulating levels of Cyclin E or DIAP1, required for cell cycle progression and apoptotic inhibition, respectively (12, 13, 14, 15, 16, 17) . Members of the Dbf2 kinase family such as Saccharomyces cerevisiae Dbf2 and Dbf20, Schizosaccharomyces pombe Sid2, Caenorhabditis elegans Lats, and mammalian Lats1 and Lats2, have been highly conserved across species (18, 19, 20, 21, 22, 23) . S. cerevisiae Dbf2 localizes to the spindle pole body (SPB; centrosome in yeast) in anaphase and the bud neck (contractile ring in yeast) in cytokinesis, functioning as an integral component of the mitotic exit network (MEN) that supervises inactivation of Cyclin-dependent kinases (Cdks) and cytokinesis; Dbf20 is also likely a component of the MEN (24, 25) . S. pombe Sid2 also localizes to the SPB throughout mitosis and is a component of the cytokinesis checkpoint and the septation initiation network (SIN), which is equivalent to the MEN machinery of S. cerevisiae (6, 26) . In contrast, the Ndr (nuclear Dbf2-related) kinase family represents a similar but distinct subfamily of the Dbf2 family. The Ndr kinase family includes S. cerevisiae Cbk1, S. pombe Orb6, C. elegans Sax-1, Drosophila Trc, Neurospora Cot-1, and the mammalian Ndr1 and Ndr2 kinases, which are involved in cellular morphogenesis (27) .
Furthermore, the kinase activation of the Dbf2 and Ndr families require a highly conserved co-activator, Mob protein family (28) . In yeast, Mob1 acts as a co-activator of the Dbf2 family, whereas another Mob, Mob2, acts as co-activator of the Ndr family (29, 30, 31, 32) . The mammalian Mob family consists of at least seven proteins, namely, Mob1A (also called Mob1 and Mats1), Mob1B (also called Mob1 and Mats2), Mob1C, Mob1D (also called Mob3 ), Mob2, Mob3 (also called Phocein) and Mob3 (33, 34, 35, 36) . Human Mob1A binds to and activates Ndr2 kinase (37) , whereas Mob1B and Mob2 interact with Ndr1 and Ndr2 kinases (23, 34) . More recently, Lats1 has been reported to interact with its activator, Mob1A, and function as a putative component of the MEN in mammalian cells (38) . These activities suggest similarities to interactions reported for Lats1 in S. cerevisiae Dbf2, S. pombe Sid2 and Drosophila Lats, which interact with S. cerevisiae Mob1, S. pombe Mob1 and Drosophila Mats, respectively (38, 39) .
Two mammalian Lats kinases have been identified: Lats1/WARTS and Lats2. Lats1-deficient mice develop pituitary hyperplasia, soft-tissue sarcomas, and ovarian stromal cell tumors (40) . Human Lats1 is phosphorylated during mitosis and associates with Cdc2 and the actin filament assembly factor Zyxin, co-localizing to the centrosomes and mitotic spindle. Overexpression of Lats1 leads to G2/M arrest as Lats1 acts as a negative regulator of Cdc2-kinase by associating with Cdc2 (21, 41, 42) . Additionally, overexpression of Lats1 results in up-regulation of the pro-apoptotic proteins Bax and Caspase-3, or activation of Omi protease, whereas Lats1 is proteolysed by Omi (43, 44, 45, 46) . Recently, Lats1 has been reported to affect cytokinesis by directly inhibiting the kinase activity of LIMK1 (47) .
We identified the other mammalian Lats kinase, Lats2 (22) , which is also phosphorylated during mitosis (48, 49) . Human Lats2 and Lats1 share 85% sequence identity in the kinase domain at the C-terminus and 52% overall sequence (22) . Similar to Lats1 and Drosophila Lats, Lats2 also appears to coordinate cell proliferation and cell death: overexpression of Lats2/Kpm results in G2/M arrest via inhibition of Cdc2 kinase activity, inhibition of G1/S transition via down-regulation of Cyclin E/Cdk2 kinase activity, and induction of apoptosis via down-regulation of apoptotic inhibitors such as Bcl-2 and Bcl-xL (50, 51, 52) . Moreover, Lats2 is a centrosomal protein that is phosphorylated by the centrosomal kinase Aurora-A; this phosphorylation is important for the centrosomal localization of Lats2 (49) . Lats2 binds Mdm2, inhibits its E3 ligase activity and activates p53, while p53 rapidly and selectively upregulates Lats2 expression in G2/M cells, thereby defining a positive feedback loop which constitutes a novel checkpoint pathway critical for the maintenance of proper chromosome number (53) . On the other hand, two miRNAs, miRNA-372 and -373, function as potential novel oncogenes in testicular germ cell tumors by inhibition of LATS2 expression, which suggests that Lats2 is an important tumor suppressor (54) . However, the mitotic functions of Lats2, including its role in the centrosome, remain unclear. Recently, knockout mice in which the LATS2 gene was partially disrupted, leaving its N-terminal amino acid sequence (amino acids 1-370) intact, showed embryonic lethality attributed to defects in cardiac growth (55) . Mouse embryonic fibroblasts (MEFs) derived from this knockout mouse exhibited defects in growth control and centrosome duplication. However, Lats2 kinase activity and two Lats Conserved Domains (LCD1 and LCD2; highly conserved sequences in the N-terminal region between Lats1 and Lats2), are required for Lats2 to suppress tumorigenicity and inhibit cell proliferation (51) . We have reported that the N-terminus of Lats2 (amino acids 1-393) interacts with Aurora-A kinase and that phosphorylation of Ser 83 in LCD1 by Aurora-A plays a role in its centrosomal targeting (49) . Therefore, the short N-terminal peptide, expressed in the partially LATS2-deficient mice, may be performing biological functions that mask the true physiological role of Lats2. Thus, we have generated complete LATS2-deficient mice, which do not express any short peptides derived from the LATS2 locus. Here 
RESULTS

Lats2 is essential for embryonic development
To elucidate the biological function of Lats2, we disrupted the entire coding region of mouse LATS2 using a gene-targeting vector. We replaced the first coding exon (E1) with the neomycin selection cassette PGK-neo, flanked by 1.6 and 6.0 kb of sequence homologous to LATS2, resulting in deletion of the translational start site. The herpes simplex virus thymidine kinase (HSV-tk) gene was used as a negative selection cassette (Fig. 1A) . After electroporation of the linearized targeting vector into D3 ES cells, the resultant clones were analyzed with Southern blots using probes A and B. One of 92 ES clones was identified as having the correct targeting (Fig.  1B, (Table S1) .
To examine the timing of developmental arrest in Lats2 -/-offspring, the genotypes of embryos generated from Lats2 +/-intercross matings were examined by PCR using the primers, KO.con5, E1-AS6, and KS.conB. The 1.9 kb band was amplified by the primers KO.con5 and E1-AS6, indicating the wild-type locus; the 1.6 kb band was amplified by the primers KO.con5 and KS.conB, indicating the Lats2-targeted allele (Fig. 1A) . We obtained 53 Lats2 -/-embryos (e.g. Nos. #7-2, #9-10 and #10-3; Fig. 1D ). Using total extracts from Lats2-deficient mouse embryo fibroblasts (MEFs), absence of the full-length mRNA and Lats2 protein was confirmed by RT +/+ mice exposed to -irradiation (dosages of 6 or 8 Gy) over a period of 469 or 40 d, respectively. There were no differences in survival rates (Fig. S1) , distinguishable phenotypes or spontaneous tumor development between Lats2 +/-and Lats2 +/+ mice (data not shown).
We analyzed the morphology of embryos at various stages and found 30 and 3 viable Lats2 -/-embryos at embryonic days 10.5 (E10.5) and E11.5, respectively (Table  S2) . However, we found no viable Lats2 -/-embryos at E12.5 or beyond, and all the Lats2 -/-embryos were smaller than their Lats2 +/+ and Lats2 +/-counterparts (Fig. S2) . Moreover, abnormal dead Lats2 -/-embryos were also observed at E10.5, E11.5, E12.5, E13.5, E15.5 and E16.5 and these exhibited severely retarded growth (Table S2 and Fig.  S2 ). At E16, one Lats2 -/-embryo presented an abnormal gross morphology whereby it remained enveloped in amnion or deciduas (data not shown). These results suggest that the lethality of Lats2-null embryos may occur before E12.5 because Lats2 is essential for embryonic development.
Although Lats2 deficiency leads to embryonic lethality, the cause of death before E12.5 remains unclear. Therefore, to clarify the role of Lats2 in embryonic development and cell growth, we performed histological analyses of Lats2 -/-embryos at various stages of development. At E13.5, histological examination revealed developmental retardation of multiple organs (Fig. 2, A and  B) . Notably, although the heart was small, the degree of developmental retardation was modest and muscular trabeculation was well-developed in the ventricle (Fig. 2, C and  D) . In contrast, the development of the nervous system was severely impaired. In the neuroepithelial layer of the fourth ventricle, a dramatic reduction in the number of nerve cells was observed, as well as infiltration by many inflammatory cells (Fig. 2, E and F) . In the spinal cord, both the number of nerve cells and density of nerve fibers were greatly reduced (Fig. 2, G and H) . Similar effects were observed as early as E10.5 (Fig. 2, I-N) , and although these embryos appeared to be alive, developmental retardation was evident in a number of organs, including the branchial arches and skeletal muscle. Notably, development of the heart was relatively normal: the ventricle had a well-developed muscular trabeculation and the atrium had a wide cavity (Fig. 2, I-L) . In contrast, the nervous system exhibited some abnormalities: the neuroepithelial layer of the fourth ventricle was thinner and contained many pyknotic nuclei (Fig. 2, M and N) .
These results suggest that in the nervous system, a deficiency in Lats2 results in growth arrest or cell death.
To confirm whether the cell death observed in Lats2 -/-embryos could be attributed to apoptosis, we performed a TdT-mediated dUTP nick-end labeling (TUNEL) assay with sections from Lats2 -/-embryos at E13.5. TUNEL-positive apoptotic cells were observed in the spinal cord (Fig. 2 , O and P) but not the heart, although they were visible in its general proximity (Fig. S3) . Taken together, these results suggest that Lats2 deficiency results in apoptosis primarily in the nervous system. These phenotypes are not necessarily similar to those of partial LATS2-knockout mice (55) .
Loss of Lats2 leads to centrosome fragmentaion
We have reported previously that Lats2 is a centrosomal protein, phosphorylated by Aurora-A kinase (49) . In order to elucidate the function of Lats2 in centrosome regulation, we examined and quantified the status of the centrosome in early-passaged (PDL7) Lats2 -/-MEFs during interphase, followed by indirect immunofluorescence analysis using anti--tubulin and anti--tubulin antibodies for visualization of centrosomes and microtubules, respectively. Increased number of centrosome was induced in Lats2-deficient MEFs, which contained >3 centrosomes per cell (Fig. 3A, top panels) . In contrast, wild-type MEFs contained a normal number of centrosomes (Fig. 3B, bottom panels) . We evaluated centrosome numbers in Lats2 -/-and wild-type MEFs (Fig. 3B) . In primary cultures (early passage), cells with multiple numbers of centrosomes (i.e. >3 per cell) were observed frequently in Lats2-deficient MEFs (24.0%), but rarely in wild-type derived from litters (7.6%). In immortalized Lats2 -/-MEFs, the multiple numbers of centrosomes also increased approximately 2.9-fold compared to wild-type (Fig. 3B) . Next, to examine whether the increased number of centrosome is associated with amplification of centriole, Lats2-deficient MEFs were stained with immunofluorescent antibodies against centrin, a component of centriolar structure (56), and -tubulin, then counter-stained with Hoechst to visualize the DNA. As shown in Fig. 3C Fig. 3E , white arrows in an inset). Furthermore, to address whether these extra -tubulin foci possess microtubule nucleating activity, we performed the standard in vivo microtubule regrowth assay. Lats2 +/+ and Lats2 -/-MEFs were treated with cold medium containing nocodazole to depolymerize microtubules, followed by replacement of fresh warm medium without nocodazole to allow regrowth of microtubules. Cells were fixed and immunostained with anti--tubulin and anti--tubulin antibodies. Two mature centrosomes of Lats2 +/+ and Lats2 -/-MEFs successfully formed two significant asters ( Fig. S4C and F, yellow arrows) . However, the extra -tubulin foci could not form any asters in Lats2 -/-MEFs (Fig. S4F , white arrows). In the case of Lats2 -/-MEFs with four mature centrosomes, these mature centrosomes could form four perfect asters (Fig. S4G) (2) . Abnormal amplification of centrosome number also occurs in failure to arrest at a G1 tetraploidy checkpoint after missegregation of the chromosome in mitosis, and is followed by a clustering of centrosomes at a single pole in subsequent tetraploid or aneuploid mitosis (2, 57, 58 (Fig. S5B) . Moreover, during telophase, we could also find clustering of centrosomes at a single pole in dividing daughter cells (Fig. S5C , white arrows in an inset). The percentage of these abnormal telophase cells was also increased approximately 3.3-fold in Lats2
-/-MEFs (14.4%) compared to wild-type (Fig. S5C , bar graph). These results indicate that loss of Lats2 leads to aberrant mitosis with misaligned chromosomes in addition to centrosome fragmentation, but not to multi-polar formation.
Loss of Lats2 results in nuclear enlargement and multinucleation
In malignant tumor cells, abnormal nuclear morphologies, such as enlarged polyploid nuclei, multinuclei, and micronuclei, are observed as frequently as centrosome abnormalities (60, 61 MEFs and evaluated the integrated and average intensity of nuclear DNA to their nuclear area ( Fig. S7A and B, respectively). As a result, the integrated intensity of DNA in Lats2 -/-MEFs was elevated in proportion to the increase in the nuclear area, whereas the average intensity of DNA in Lats2 -/-MEFs kept a constant range of value in no inverse proportion to the increase in the nuclear area. These results suggest that the increased nuclear size or number in Lats2 -/-MEFs were associated with polyploidy. Therefore, it is likely that loss of Lats2 results in nuclear enlargement, multinucleation and polyploidy.
Taken together with previous reports that multinucleation causes subsequent failure of cytokinesis (62), our data suggest that Lats2 also regulates these processes.
Loss of Lats2 leads to cytokinesis failure
To determine whether Lats2 regulates cytokinesis, the fate of Lats2-deficient MEFs was monitored by time-lapse video microscopy, where differential interference contrast (DIC) images were captured at 1 min intervals. As expected, the wild-type MEFs underwent normal cell cleavage and the two daughter cells showed complete separation within 108 min after metaphase ( MEFs also possessed multiple centrosomes (Fig. 3C, type III) . Thus, the loss of Lats2 function leads to abnormal mitotic progression and subsequently inhibits cytokinesis. This suggests that Lats2 specifically regulates mitosis.
In contrast, Lats1 has been reported to regulate cytokinesis by inhibiting LIMK1 activity and by acting as a MEN kinase by binding Mob1A (38, 47) and to be activated by membrane-targeted Mob1A and B but not Mob2 (28) . However, it remains unclear whether Lats2 interacts with the Mob family. Mob1A and Mob1B share a high degree of sequence similarity (ca. 95%) but both show less homology to Mob2 (ca. 40%) (33) . Since it is known that Ndr1, but not Lats1, interacts with Mob2 (38), we speculated that Lats2 may interact with Mob1A or Mob1B. To test this, we co-transfected 293T cells with GFP (green fluorescent protein)-tagged human Lats2 and 3Flag-tagged Mob1A or Mob1B. Immunoprecipitation experiments with anti-GFP antibody revealed that Lats2 associates with both Mob1A and Mob1B (Fig.  S8, A and B) . Furthermore, we found that the autophosphorylation activity of Lats2 was markedly enhanced by Mob1A; this was revealed by subjecting Lats2 proteins immunoprecipitated from 293T cells that co-expressed Lats2 with Mob1A or Mob1B to in vitro kinase assays in the presence of 32 P-ATP (Fig.  S8B , upper panel). Interestingly, the kinase activity of Lats2 also appeared to be strongly stimulated when the Lats2-expressing cells were treated with the protein phosphatase inhibitor okadaic acid. Furthermore, this okadaic acid-induced elevation in Lats2 autophosphorylation was further enhanced by the binding of Mob1A (Fig. S8B ). This effect of Mob1A increased in proportion to its expression levels (Fig.  S8C) . Thus, like Lats1, which acts as a MEN kinase upon binding to Mob1A (38) , Lats2 may also act as a MEN kinase by interacting with Mob1A. That the activation of Lats2 requires not only the binding of Mob1A but also phosphatase inhibition suggests Lats2 may form an activation complex that is similar to other Lats-Mob complexes such as Lats1-Mob1A, Dbf2-Mob1, Sid2-Mob1 and Lats-Mats (26, 38, 39, 63) .
Loss of Lats2 results in an acceleration of exit from mitosis
When the proliferation rate of cells that completely lacked LATS2 expression was compared to that of wild-type cells derived from littermates, the former were found to grow faster (Fig. 5A ). MEFs that are partially deficient in LATS2 expression have a similar phenotype (55) . Thus, Lats2
-/-cells grow faster regardless of apparent mitotic defects such as centrosome fragmentation, chromosome misalignment and cytokinesis failure, suggesting that MEFs that completely lack LATS2 expression have an impairment in a checkpoint machinery that governs the mitotic arrest. To address which mitotic stage is sped up in Lats2 -/-MEFs, we divided the mitotic progression into four parts based on the morphology of growing cells: part I, from initiation of mitosis to round morphology; part II, from round morphology to ingression of cleavage furrow (which almost corresponds from prometaphase to late anaphase); part III, from ingression to the completion of furrow formation (which almost corresponds from late anaphase to telophase); part IV, from cleavage furrow formation to cell division (Fig. 5C) (Fig. S9, 0 hrs) . This result suggests that mitotic arrest induced by at least the spindle damage is not defective in Lats2-deficient cells. Therefore, these observations indicate that loss of Lats2 function results in an acceleration of exit from mitosis.
Loss of Lats2 results in down-regulation of mitotic regulators
It has been shown previously that when mitotic regulators such as Aurora and polo-like kinases are down-regulated by siRNA or the injection of specific antibodies, highly defective mitosis ensues (5, 59, 64, 65, 66) . Since the loss of Lats2 induces various typical mitotic defects, including fragmentation of centrosomes, chromosome misalignment, and cytokinesis failure (as mentioned above), we examined the protein levels of various mitotic regulators in Lats2-deficient cells. We found that the protein levels of major mitotic regulators such as Aurora-B, Plk1 and Cyclin B1 were all markedly decreased in Lats2 -/-MEFs (Fig. 6A) . To test whether these Lats2 -/--specific reductions are due to post-translational degradation, we subjected the total RNAs of Lats2
+/-and Lats2 -/-MEFs to RT-PCR analysis employing a series of specific primers (Fig. 6B) . Since the Aurora-B mRNA level was identical between the three MEF types, it appears that these proteins were present at reduced levels in Lats2
-/-MEFs due to post-translational degradation. Notably, while the Western blot analysis seemed to indicate the complete absence of Cyclin B1 protein in Lats2 -/-cells, small amounts of this protein could be immunoprecipitated from these cells with anti-Cyclin B1 antibody (Fig. 6C) . Thus, endogenous Cyclin B1 protein is present in Lats2 -/-cells at dramatically decreased levels. To address the relative stabilities of Aurora-B, Plk1 and Cyclin B1 in Lats2 +/+ and Lats2 -/-MEFs, both cells were exposed to a protein synthesis inhibitor, cycloheximide (CHX), and collected at the indicated time (Fig. 6D ). When these cell extracts were subjected to Western blotting with anti-Aurora-B, Plk1 and Cyclin B1, the levels of these mitotic proteins were markedly decreased after CHX treatment in Lats2 -/-more than Lats2 +/+ MEFs, although the levels of Aurora-B and Cyclin B1 were also gradually decreased in wild-type MEFs To estimate the relative amount of these mitotic proteins in Lats2 +/+ and Lats2 -/-MEFs at each indicated time after CHX treatment, the amounts of these proteins were quantified by densitometry, and the ratio of each protein was normalized by the ratio of GAPDH, a loading control (Fig. 6E) . Notably, the normalized ratio of Aurora-B and Plk1 were markedly reduced in Lats2 -/-MEFs (red circles and pink squares, respectively), whereas the ratio of Cyclin B1 that decreased in Lats2 -/-MEFs was slightly different compared with that of Cyclin B1 in Lats2 +/+ MEFs (orange and green diamonds, respectively). These results suggest that Lats2 is more important for stabilization of Aurora-B and Plk1 than Cyclin B1. It has been shown that, along with Cdc20, CENP-E and Aurora-A, Aurora-B, Plk1 and Cyclin B1 appear to be degraded by the proteasome pathway at distinct points during mitotic exit or G1 phase (67) . This suggests that Lats2 is involved in stabilization of Aurora-B, Plk1 and Cyclin B1. Since these mitotic proteins are regulated spatially, we examined how the loss of Lats2 affects their subcellular distributions (Fig. S10) . We found that Aurora-B localized normally to the chromosome during G2 and metaphase and at the midbody during cytokinesis in Lats2 -/-as well as Lats2 +/+ MEFs (Fig. S10A ). In addition, we could not observe any change in kinetochore-like localization of Aurora-B in Lats2 -/-MEFs (Fig. S11) . We could also observe the normal centrosomal and midbody localizations of Plk1 in Lats2 -/-as well as Lats2 +/+ MEFs (Fig. S10B) . Moreover, there was no influence in the nuclear transport and centrosomal localization of Cyclin B1 in Lats2 -/-MEFs (Fig. S10C) . Thus, it is unlikely that loss of Lats2 affects the subcellular localization of Aurora-B, Plk1 and Cyclin B1. On the other hand, the E2F1 protein levels were also slightly reduced in homozygous MEFs (Fig. 6A) . In contrast, the levels of Cyclin D1 (a G1-cyclin) were increased in Lats2 +/-and Lats2 -/-MEFs. Notably, the Lats2 -/-MEFs showed decreased levels of the inhibited form of Cdc2 (whose tyrosine 15 is phosphorylated) but normal levels of the active form. This suggests that Lats2 -/-cells contain more active Cdc2 than Lats2 +/+ or Lats2 +/-MEFs. Thus, it appears that even though their Cdc2 kinase proteins remain activated, Lats2-deficient cells are forced to exit mitosis without completing the process; this forced exit may be due to the irregular degradation of major mitotic regulators. This suggests that loss of Lats2 leads to defective mitotic exit and subsequently induces a premature M/G1 phase transition.
It has been reported that critical mitotic regulators including Aurora-B, Plk1 and Cyclin B1 are tightly regulated by their protein degradation with the anaphase-promoting complex/cyclosome (APC/C) that is activated by Cdh1 at the M-to-G1 transition (67, 68, 69) . Therefore, to examine whether inactivation of the APC/C-Cdh1 restores the levels of the reduced mitotic regulators in Lats2
-/-MEFs, we knocked down endogenous Cdh1 in Lats2 -/-MEFs by siRNA. As shown in Fig.  6F , the levels of Aurora-B, Plk1 and Cyclin B1 proteins were successfully restored in primary Lats2 -/-MEFs by introduction of Cdh1 siRNA, whereas negative control GL2 did not restore any protein levels. Moreover, we also obtained the similar results in immortalized Lats2
-/-MEFs to the primary cells (Fig. 6G) . These results indicate that reduction of mitotic proteins in Lats2-null cells depends on the Cdh1-mediated APC/C proteasome pathway, suggesting that Lats2 could prevent a premature mitotic exit by the negative regulation of this pathway.
Taken together, our data suggest that Lats2 is required for a wide variety of critical mitotic events, namely, centrosome regulation, chromosome alignment, precise progression of mitotic exit, and completion of cytokinesis. They also suggest that Lats2 may govern the stability of Aurora-B, Plk1, and Cyclin B1 by a negative regulation of the APC/C-Cdh1 pathway. However, it remains unclear whether Lats2 directly regulates the protein levels of these mitotic regulators. (55) . However, in our complete LATS2-knockout mice we observed no defects in cardiac growth at any embryonic developmental stage (Fig. 2) . In brief, the hearts developed normally, without any trabeculation defects or thinner myocardium, but were smaller than those of the wild-type.
DISCUSSION
Embryonic lethality of a total LATS2 knockout in mouse is due to disrupted development of the nervous system
Instead, we found that our complete LATS2-knockout embryos exhibited severe abnormalities in the nervous system, as well as nerve cell death. These results appear contradictory to previous data showing that overexpression of Lats2 induces apoptosis in human cancer cells (50, 52) . However, Hou et al. (26) reported that Sid2 forms homodimers in its inactive form, whereas SIN-dependent phosphorylated Sid2 associates with Mob1 as an active complex. In a yeast two-hybrid assay, the N-terminus of Lats1 was shown to associate with its own C-terminus (21) , and using a pull-down assay, we found recently that Lats2 can associate with Lats1 (Yabuta et al., unpublished results). Thus, in the normal developmental processes of the mouse nervous system, Lats2 is predicted to associate with Lats1, which is prominently expressed in tissues of ectodermal origin, such as the neural tube and head fold neuroepithelium. It might also be predicted to inhibit irregular induction of apoptosis by excess Lats1, via a mechanism similar to Sid2 self-association. Thus, loss of Lats2 may cause inappropriate activation of Lats1 and lead to irregular apoptosis in the nervous system, as observed in the spinal cord of our complete LATS2-knockout embryos.
Moreover, unlike Lats1, which is expressed mainly in tissues of ectodermal origin during embryonic developmental stages E8.5-E10.5, Lats2 is prominently expressed in tissues of mesodermal origin (55) . However, it remains unclear whether or not Lats2 is expressed in tissues of ectodermal origin (including the nervous system) after E10.5. Since mouse and human Lats2 may be expressed in the brain of normal adult mice, and the brain and spinal cord of humans, respectively (22) , it is likely that Lats2 is expressed and functions in the nervous system during embryogenesis. Further studies are required to establish the relationship between Lats2 and Lats1 in respect to embryonic development.
Mechanism of centrosomal regulation by Lats2
Centrosome dysregulation, which leads to centrosome overduplication, is associated with tumor progression in most human cancers such as the breast, prostate, and colon (2, 4). The centrosome checkpoint ensures that centrosomes duplicate only once during the cell cycle. Loss of centrosome checkpoint function leads to centrosome amplification including centriole over-duplication and centrosome fragmentation, resulting in aberrant mitotic spindle formation followed by genomic instability and aneuploidy. Inactivation of Lats2 caused centrosome abnormality but not aberrant mitotic spindle formation such as multipolar spindle formation. How does centrosome abnormality occur in Lats2-deficient cells? Recently-suggested models may provide insight into the mechanism of centrosome abnormality: one such model proposes that direct deregulation of centrosome duplication may bypass the cell division cycle, leading to centrosome overduplication, and the centrosome amplification so-called (70) ; another suggests that failure of cytokinesis results in tetraploidy, resulting in more than one centrosome per cell (57, 71) . It is thought that Cyclin E/Cdk2 kinase plays a key role in the regulation of centrosome duplication through phosphorylation of the nucleolar proteins Nucleophosmin (NPM/B23), a centrosomal kinase (Mps1) and a centrosome duplication-promoting factor CP110 (72, 73, 74, 75) . Recent publications have indicated that inactivation of p53, Skp2, E2F3, or Pml in mice causes aberrant centrosome amplification that is related to activation of Cyclin E/Cdk2 kinase (76, 77, 78, 79) . However, centrosome abnormality in Lats2-deficient cells might not be accompanied by activation of Cyclin E/Cdk2, as the protein level of Cyclin E was unaffected between Lats2-deficient and wild-type MEFs (Fig. 6A) . Moreover, our results demonstrated that Lats2-deficient cells aborted cytokinesis, and that this was followed by binucleation, suggesting that failures of cell division may contribute to the increased number of centrosomes in Lats2-deficient cells (Fig. 3C and D, type III) . However, some Lats2-deficient cells possessed >4 centrosomes per cell (e.g. 7 per cell, data not shown), a finding which does not correspond to the idea of centrosome number being a consequence of defects in cell division. In fact, we demonstrated that loss of Lats2 leads to the fragmentation of pericentriolar material (Fig. 3C and D, type I) . In addition, a recent report has shown that depletion of Lats2 in HeLa cells by siRNA treatment blocks the recruitment of -tubulin to centrosomes; this effect was also observed when Ajuba, a centrosomal LIM protein, was depleted (80) . Taken together, these results suggest that centrosome abnormality in Lats2-deficient cells may be responsible for both the centrosome fragmentation and the observed defects in cytokinesis. Conversely, it is also possible that the centrosome abnormality is caused by the dysfunction of mitotic spindle as a collapsed spindles, by which cytokinesis could be disturbed.
Regulation of cytokinesis by Lats2
Recently, it has been reported that a number of novel centrosomal proteins such as Cep55 and Su48 regulate cytokinesis in mammalian cells (81, 82) . We have shown here that, like these centrosomal proteins, the centrosomal protein Lats2 localizes at the midbody during late mitosis and plays a role in cytokinesis. Although a previous study has revealed that partial LATS2-knockout MEFs show increased retention of the cytoplasmic bridge (55), our results indicate that this does not occur in MEFs that completely lack LATS2 expression. This suggests that the cell division cycle in the latter cells may progress without telophase arrest due to cytokinesis failure. Supporting this is that the Lats2-deficient cells proliferated faster than the wild-type cells derived from littermates (Fig. 5A) . The partial LATS2-knockout MEFs also showed increased growth rates (55) . In addition, we demonstrated that Lats2-null cells cause an acceleration of exit from mitosis (Fig. 5B) . Notably, compared to Lats2-null cells, wild-type MEFs take longer and more variable time span to complete cytokinesis (Fig. 5B, part IV (38, 47) . It is possible that Lats2 also functions as a MEN kinase since we found that Lats2 can interact with both Mob1A and Mob1B (Fig. S8) . Interestingly, the recruitments of the Lats1-Mob1A and the Lats1-Mob1B complexes to the plasma membrane are required for their activations (28) , whereas our data revealed that the Lats2-Mob1A complex is activated without such recruitment (Fig. S8) . These results suggest that the biological function of the Lats2-Mob1A is not identical to that of the Lats1-Mob1A/B. To clarify whether Lats2 acts as a bona fide MEN kinase in mitotic exit, further studies will be required. In particular, it will be of interest to determine whether Lats2 is activated by Mob1A and Mob1B during mitotic exit and how Lats2 helps to regulate mitotic exit and cytokinesis. Identification of the phosphorylation target of Lats2 kinase (e.g. Cdc14A or Cdh1) will also be informative. Moreover, it may be of interest to determine whether Lats2 is involved in the activation of separase, which is a sister chromatid-separating protease. This is because the activation of separase in budding yeast, which induces the release of Cdc14 by downregulating protein phoshatase 2A and Cdc55, initiates mitotic exit (83) .
We have also demonstrated that the protein levels of major mitotic regulators such as Aurora-B, Plk1, and Cyclin B1 are markedly decreased in Lats2 -/-MEFs (Fig. 6 ). It will be of interest to determine whether Lats2 regulates these mitotic regulators directly or indirectly. We have reported previously that Lats2 co-localizes with Aurora-A at the centrosome, and other recent reports have indicated that Aurora-A, Plk1, and Cyclin B1 localize at the centrosome (1, 66, 84) . Thus, it is likely that Lats2 forms a functional complex with these mitotic proteins. However, it remains unclear whether Lats2 can directly phosphorylate these proteins in vitro or in vivo.
It has been demonstrated that the proteins Aurora-B, Plk1 and Cyclin B1 are rapidly degraded by the proteasome pathway at distinct times during mitotic exit (67) . Therefore, the degradation of these proteins may be responsible for the rapid progression of the M/G1 transition induced by loss of Lats2 function. In fact, we have shown a possibility that the dramatic reduction of these mitotic proteins in Lats2 -/-MEFs is provoked by a profound dysregulation of the APC/C-Cdh1 proteasome pathway and the timing of exit from mitosis is consequently accelerated. In budding yeast, the Cdh1/Hct1 has been reported to be dephosphorylated by Cdc14 phosphatase and be subsequently activated in order to initiate the destruction of B-type Cyclin in late mitosis (85) , while Dbf2-Mob1 complex has been shown to sustain Cdc14 release from the nucleolus to keep its phosphatase activity under the MEN signaling (86) . Thus, it is likely that Dbf2 is a component of the budding yeast MEN and is a positive regulator of mitotic exit and cytokinesis. However, in mammalian cells, Lats2 is required for cytokinesis but negatively regulates mitotic exit because our presented data suggest that Lats2 delays mitotic exit through inactivation of Cdh1 (Fig.  5 and 6 ). In contrast to the MEN, the fission yeast SIN primarily regulates cytokinesis and is dispensable for mitotic exit. The SIN mutants containing sid2 cause cytokinesis errors and results in multinucleated cells. In fact, Lats2-deficient cells also cause cytokinesis failure and results in multinucleated cells (Fig. 4) . In addition, these cells lead to the instability of important mitotic kinases in undergoing cytokinesis, Plk1 and Aurora-B (Fig. 6) . Therefore, the signaling network to which Lats2 belongs appears to behave more like the SIN than the MEN. Furthermore, there was a decrease in the inhibitory phosphorylation of tyrosine 15 on Cdc2, in Lats2 -/-MEFs, indicating enhanced activation of Cdc2 compared to wild-type MEFs. These results are consistent with a previous report that Plk1 depletion results in elevated Cdc2 protein kinase activity and incomplete separation of sister chromatids (64) . In light of the above results, we propose that Lats2 is one of the critical mitotic regulators of centrosomal integrity and completion of cytokinesis, that operates via stabilization of mitotic regulators such as Aurora-B, Plk1 and Cyclin B1.
In summary, we have demonstrated that completely LATS2-deficient mice show partly similar, but essentially distinct phenotypes, from partially LATS2-deficient mice. We also report here novel phenotypes of LATS2-deficient cells that was not reported previously (55) . These distinct phenotypes and novel findings are as follows: Firstly, embryonic lethality of the complete LATS2-knockout mouse due to severe developmental defects in the nervous system, but not in cardiac growth or structures; secondly, MEFs from complete LATS2-knockout embryos exhibit a wide variety of mitotic defects such as centrosome fragmentation and misaligned chromosomes; thirdly, complete LATS2-knockout MEFs exhibit cytokinetic defects without telophase arrest, followed by tetraploidy formation, nuclear enlargement and multinucleation. Our results reported here suggest that Lats2 is required for cytokinesis. In addition, we have also demonstrated that complete
LATS2-knockout
MEFs exhibit an acceleration of exit from mitosis and down-regulation of critical mitotic regulators, suggesting that Lats2 is an essential mitotic regulator that governs the stabilization of other mitotic regulators. Fig. 1 . Targeted disruption of the complete mouse LATS2. A, schematic representation of wild-type (WT) Lats2 locus, targeting vector, and targeted locus. In the targeting vector and targeted locus, the neomycin selection cassette replaces the first coding exon (E1), in order to disrupt the complete LATS2 gene. On the short arm, an ApaLI digest generates a 4.2 kb fragment from the WT allele and a 5.5 kb fragment from the targeted allele. On the long arm, a BanI/EcoRI double digest generates a 7.1 kb fragment from the WT allele and 8.8 kb fragment from the targeted allele. Short and long arm fragments are recognized by probes A and B, respectively. B, southern blot analysis of genomic DNA from ES clones (D3, 2, 22, 26, 27, and 28). Genomic DNA was digested with ApaLI (left panel) and BanI/EcoRI (right panel) and hybridized with probes A and B, respectively. The WT (4.2 and 7.1 kb) and mutated fragments (5.5 and 8.8 kb) are indicated. D3 is a negative control. C, southern blot analysis of genomic DNA from the tails of offspring obtained from heterozygote intercrosses. Genomic DNA was digested with ApaLI and probe A was used for hybridization of the blot. Fragments corresponding to WT and mutated alleles (4.2 and 5.5 kb, respectively) are indicated. D, PCR analysis of genomic DNA of embryos obtained from heterozygote intercrosses. Amplification products corresponding to WT and mutated (KO, knockout) alleles (1.9 and 1.6 kb, respectively) are indicated. Genomic DNA from tails of mice Nos. 10 and 11 in C were used as control templates. , and Lats2
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-/-MEFs were resolved by SDS-PAGE, followed by Western blotting with antibodies specific to the proteins indicated. Anti-GAPDH antibody was used as loading control. Asterisks indicate non-specific bands. B, RT-PCR analysis of mRNA expression level of Aurora-B in Lats2
+/-and Lats2 -/-MEFs. The indicated amounts of total RNA from each MEF were reverse-transcribed and amplified by PCR using specific primer pairs for the genes indicated (Lats2, Aurora-B and GAPDH). C, immunoprecipitates obtained from Lats2 +/+ and Lats2 -/-MEF extracts by using the anti-Cyclin B1 antibody were resolved by SDS-PAGE, followed by Western blotting with anti-Cyclin B1 antibody. As a negative control, immunoprecipitation with normal mouse IgG (NMG) was performed. As a positive control, extracts from asynchronous HeLa S3 cells (AS) were used. The asterisk indicates non-specific bands. D, Western blot analysis of the stability of Aurora-B, Plk1 and Cyclin B1 proteins after cycloheximide (CHX) treatment (50 g/ml) for the indicated time points (hours). GAPDH is a loading control. The ratio of each band is shown relative to the amount of each protein in absence of CHX (CHX (-)). Quantification of the intensity of each band was performed by scanning the blots with the fluorescent image analyzer FLA-7000 and analysis with the Multi Gauge software (FUJIFILM, Tokyo, Japan). E, the ratio of Aurora-B, Plk1 and Cyclin B1 proteins obtained from (D) were normalized by the ratio of GAPDH. Aurora-B, Plk1 and Cyclin B1 were shown as circles, squares and diamonds, respectively. Black, blue and green colors, Lats2 +/+ MEFs; Red, pink and orange colors, Lats2 -/-MEFs. F and G, restoration of the levels of Aurora-B, Plk1 and Cyclin B1 proteins by knockdown of Cdh1 in Lats2 -/-MEFs. The siRNA duplex targeted for mouse Cdh1 (siCdh1) or firefly luciferase as a negative control (GL2) were introduced into primary (F) and immortalized (G) Lats2 -/-MEFs by electroporation. Lysates (70 g per lane) from the siRNA-introduced Lats2 -/-MEFs were resolved by SDS-PAGE, followed by Western blotting with antibodies specific to the proteins indicated. Anti-GAPDH antibody was used as a loading control. As controls, lysates (100 g per lane) from intact primary Lats2 +/+ and Lats2 -/-MEFs were used. Cdc2/PSTAIRE polyclonal, and FLAG M2 monoclonal; from Zymed (San Francisco, CA), Plk, Cdh1 and Nucleophosmin monoclonals; from BD Bioscience (San Jose, CA), Aurora-B monoclonal; from Cell Signaling (Beverly, MA), Cyclin D1 monoclonal and phospho-Tyr15-Cdc2 polyclonal; from Santa Cruz (Santa Cruz, CA), Cdc14A, Cyclin E and E2F1 polyclonals, Cdc25A monoclonal and Cyclin B1 moclonal/polyclonal; from MBL (Nagoya, Japan), Cdc25B polyclonal and Cdc25C monoclonal; Research Diagnostics Inc. (Flanders, NJ), GAPDH monoclonal; Upstate-Millipore (Bedford, MA), phospho-Histone H3 (Ser10) polyclonal; and Sawady Technologies (Tokyo, Japan), EGFP polyclonal.
Immunofluorescence staining MEFs growing exponentially and transfected HeLa S3 cells were plated on coverslips and fixed for 10 min at room temperature in 4% formaldehyde in PBS, 0.1% Triton X-100 in PBS(-), then 0.05% Tween-20 in PBS. To visualize centrosomes and microtubules, cells were incubated with anti--tubulin and -tubulin antibodies, followed by incubation with AlexaFluor 488 and 594 (Molecular Probes, Eugene, OR)-conjugated anti-rabbit/mouse IgG in TBST (100 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.05% Tween-20) containing 5% fetal bovine serum (FBS), as described previously (49) . Aurora-B, Plk1, Cyclin B1 and phosphor-Histone H3 staining were performed by the method similar to the above-mentioned. For centrin staining, cells were fixed in cold-methanol/acetone (1:1) for 20 min at -20°C, washed with PBS(-), and then stained with anti-Centrin antibody in TBST containing 5% BSA. DNA was stained using Hoechst 33258 (Sigma, St. Louis, MO) and cells were observed using a BX51 microscope (Olympus) or a confocal laser-scanning microscope LSM510 (Zeiss).
Plasmids and transfections cDNA of human Lats2-kinase dead (KD, K698M) was amplified by PCR using pCMVmyc-full length human LATS2 as a template and the PCR products were ligated into the BamHI and XhoI sites of pEGFP3B (49) . cDNAs of human MOB1A and MOB1B (33) were PCR amplified from a HeLa cDNA library and ligated into the AscI and NotI sites of p3Flag+AscI (a modified version of p3xFLAG-CMV-7.1 (Sigma, St. Louis, MO) containing the linker HindIII-AscI-BmgBI-NotI (constructed by Dr. I. Nagamori, Osaka University, Japan). All amplified sequences were confirmed by DNA sequencing. The plasmids were transiently transfected into human embryonic kidney 293T or HeLa S3 cells using LipofectAMINE and PLUS reagents, according to the manufacturer's instructions (Invitrogen, Carslbad, CA).
Immunoprecipitation, Western blot analysis, and in vitro kinase assay Protein lysates were prepared by incubating cells in TNE250 lysis buffer (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 1 mM EDTA, 0.2% NP-40, 1 mM PMSF, 1 g/ml aprotinin, 10 g/ml leupeptin, 1 g/ml pepstatine A, 1 mM NaF, 1 mM Na 3 VO 4 and 10 mM -glycerophosphate) at 4°C for 30 min. After centrifugation, cleared lysates were immunoprecipitated and separated by SDS-PAGE. Immunoprecipitations were performed as described previously (49), with a modified wash buffer. In brief, cleared lysates were incubated with 2 g of anti-GFP polyclonal or Cyclin B1 antibodies for 3 h at 4°C, after which immune complexes were harvested by the addition of 30 l of 50% protein A-sepharose (Amersham Pharmacia Biotech, Piscataway, NJ) slurry, and washed six times with NETN150 buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA and 0.05% NP-40). Western blotting was performed using anti-phospho Tyr15 Cdc2 polyclonal antibody (1:200) in TBST containing 1% BSA. Western blotting using antibodies other than anti-phospho Tyr15 Cdc2 was performed in TBST containing 5% non-fat milk. For in vitro Lats2-kinase assay, 293T cells were transfected with GFP-Lats2-WT or -KD and 3Flag-Mob1A or -Mob1B, and treated with the serine/threonine phosphatase inhibitor okadic acid (0.1 M) 3 h before harvest of lysates. These cell extracts were immunoprecipitated with anti-GFP antibody. After wash, these immunoprecipitates were incubated in Lats2-kinase buffer (20 mM Pipes, pH 6.5, 4 mM MnCl 2 , 1 mM DTT, 1 mM NaF, 1 mM Na 3 VO 4 ) containing 20 M ATP and 10 Ci [ - 32 P] ATP. Proteins were separated by SDS-PAGE, followed by Western blotting with anti-FLAG M2 or anti-GFP antibodies. Auto-phosphoryalted Lats2 proteins were detected by autoradiography.
RT-PCR analysis Total RNA was extracted from MEFs using the AGPC (Acid Guanidinium-Phenol-Chloroform) method. cDNAs were synthesized from 3, 30, and 300 ng of RNA using the High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA). PCR was performed with the following primers pairs: mouse Lats2: forward, 5'-ACTTACTCTGGAAATAGCCGGC-3', reverse, 5'-AATATCGGATTTCCCTGAGAGC-3'; mouse Aurora-B: forward, 5-TTGGCTGAGAACAAGAGTCAG-3'; reverse, 5'-ATCCGACGATACGTCTCACTG-3'; mouse GAPDH: forward, 5'-TCACCATCTTCCAGGAGCGAG-3', reverse, 5'-GCTGTAGCCGTATTCATTGTC-3', using the following cycle profile: 95°C for 3 min, 95°C for 30 s, 55°C for 30 s, 72°C for 1 or 2 min, for 30 cycles, followed by extension at 72°C for 3 min. PCR products were subjected to agarose gel electrophoresis, followed by ethidium bromide staining.
Time-lapse imaging and analysis Asynchronously grown MEFs were plated into 35-mm glass-base dishes (IWAKI, Tokyo, Japan) and maintained at 37°C using a stage heater on a model IX71 fluorescent microscope (Olympus) equipped with a humidity chamber and CO 2 injection control system. The images were obtained using a high-sensitivity CoolSNAP-HQ CCD camera (Olympus), a Z-axis motor and 40x UplanApo Oil Iris objective lens, and were collected at 1 min intervals by MetaMorph imaging analysis software (Universal Imaging Ltd., Buckinghamshire, UK).
siRNA For knockdown of mouse Lats2 and mouse Cdh1 in MEFs, we used siRNA duplexes of the following sequences: mouse Lats2, 5'-GUUUGGACCUUAUCAAAAAdTdT-3' and 5'-UUUUUGAUAAGGUCCAAACdTdT-3'; mouse Cdh1, 5'-UGAGAAGUCCCCCAGCCAGdTdT-3' and 5'-CUGGCUGGGGGACUUCUCA-3'; luciferase (GL2), 5'-CGUACGCGGAAUACUUCGAdTdT-3' and 5'-UCGAAGUAUUCCGCGUACGdTdT-3'. The Lats2 siRNA duplexe was transfected into growing MEFs by Lipofectamine 2000 reagent, according to the manufacturer's instructions (Invitrogen). These cells were fixed at 72 hrs after the transfection as described above. The Cdh1 siRNA was introduced into growing MEFs by electroporation using Microporator-Mini MP-100, according to the manufacturer's instructions (Digital Bio Technology, Seoul, Korea). These cells were lysed at 72 hrs after the electroporation.
Mitotic index Mitotic index was determined as percentage of anti-phospho-Histone H3-positive round cells in the total population (91). MEFs were treated with 200 ng/ml nocodazole for 18 hrs and subsequently released from nocodazole arrest by replacement of the culture medium with a fresh medium without nocodazole. After incubation for the indicated times, these cells were fixed and immunostained with anti-phospho-Histone H3 antibody and counterstained with Hoechst 33258. These cells were counted using the BX51 microscope.
Microtubule regrowth assay Microtubule regrowth assay was performed as described previously (92). In brief, MEFs were treated with cold medium containing 25 M nocodazole for 40 min to depolymerize microtubules, and subsequently incubated in fresh warm medium without nocodazole for 15 min to regrow the microtubules. These cells were fixed and immunostained with anti--tubulin and -tubulin antibodies as described above.
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87. Tybulewicz, V. L., Crawford, C. E., Jackson, P. K., Bronson, R. T., and Mulligan, R. C. +/+ cells and Lats2 -/-cells at putative post-S phase, respectively. The integrated intensity of DNA in a putative G1 phase-cell is under 100 x 10 3 . In each experiment, over 450 cells were counted and plotted. In each cell, the nuclear area, the integrated intensity and the average intensity of DNA were quantified using MetaVue software (Molecular Devices). Immunoprecipitates obtained from the cell extracts by using anti-GFP antibody were incubated in kinase buffer containing [ -32 P] ATP. The proteins were separated by SDS-PAGE and subjected to Western blotting with anti-GFP or anti-FLAG M2 antibodies. The auto-phosphorylated Lats2 proteins were detected by autoradiography. The asterisk indicates degraded GFP-Lats2-KD products. C, Lats2 kinase is activated in a Mob1A dose-dependent manner. 293T cells were co-transfected with GFP-Lats2-WT (4 g of the plasmid) and different amounts of 3Flag-Mob1A (0.0001, 0.001, 0.01, 0.1 or 1.0 g). As negative controls, extracts of cells co-transfected with 3Flag-Mob1A (4 g of the plasmid) and either GFP-vector or GFP-Lats2-KD were used. In vitro kinase assays and Western blotting were performed as in B. +/+ (left panels) and Lats2 -/-(right panels) MEF were immunostained with anti-Aurora-B (green) and anti-phospho-Histone H3 antibodies (red) and counterstained with Hoechst (blue). B, Lats2 +/+ (left panels) and Lats2 -/-(right panels) MEF were immunostained with anti-Plk1 (red) and anti--tubulin antibodies (green) and counterstained with Hoechst (blue). C, Lats2 +/+ (left panels) and Lats2 -/-(right panels) MEF were immunostained with anti-Cyclin B1 (red) and anti--tubulin antibodies (green) and counterstained with Hoechst (blue). Scale bars, 10 m. 
